Pulmonary Disease Doctors in Richardson, TX Accepting Medicare

4 Pulmonary Disease doctors found. Showing 1 - 4

Dr. Mily Sheth, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2821 E President George Bush Hwy Ste 407, Richardson, TX 75082 Phone: 972-680-0668

Dr. Scott G Donaldson, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 375 Municipal Dr, Suite 218, Richardson, TX 75080 Phone: 972-680-0666

Michael Lawrence Foster, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2821 E George Bush Hwy., Ste 407, Richardson, TX 75082 Phone: 972-680-0668    Fax: 972-680-2499

Aritra Sen, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2821 E Bush Hwy Ste 407, Richardson, TX 75082 Phone: 972-680-0668

News Archive

Using nanocarrier-delivered microRNA to target sepsis

One in three patients who die in the U.S. dies of sepsis, according to the Centers for Disease Control and Prevention. It is one of the leading causes of death in intensive care units and, with an estimated price tag of $20 billion in 2011, the most expensive condition that hospitals treat.

More taxes and drab packages for cigarettes to deter the young from smoking

From 1st July 2012 companies making cigarettes will be allowed only to have a brand name and a graphic health warning on their cigarette packs. There has been a huge debate over this issue. Trade experts believe that this move could mean that the Federal Government may have to cough up more than $3 billion a year to cigarette companies. Tim Wilson from the Institute of Public Affairs also believes that this would cost taxpayers $3.4 billion a year in compensation to tobacco companies. However Australia will be the first country to introduce such a measure.

Perceived risk of COVID-19 infection increases likelihood of depression among people in Soweto

Associations between depression and issues such as hunger, violence, poor healthcare, and high rates of poverty have long been recognized, but this study is the first to look at the mental health effects of the pandemic and national lockdown in South Africa under those conditions.

Study: Ultra-low rituximab dose maintains low disease activity for most RA patients

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study, the majority of rheumatoid arthritis patients on an ultra-low dose of the drug rituximab maintained low disease activity for up to four years, and rarely needed to switch to other biologic drugs or glucocorticoids to control their disease.

Read more Medical News

› Verified 5 days ago